Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease

被引：1134

作者：

Dai, Wenhao ^{[1
,2
]}

Zhang, Bing ^{[3
,4
]}

Jiang, Xia-Ming ^{[5
]}

Su, Haixia ^{[1
,6
]}

Li, Jian ^{[1
,6
]}

Zhao, Yao ^{[3
,4
]}

Xie, Xiong ^{[1
,6
]}

Jin, Zhenming ^{[3
,4
]}

Peng, Jingjing ^{[1
,6
]}

Liu, Fengjiang ^{[3
,4
]}

Li, Chunpu ^{[1
,6
]}

Li, You ^{[8
]}

Bai, Fang ^{[3
,4
]}

Wang, Haofeng ^{[3
,4
]}

Cheng, Xi ^{[1
]}

Cen, Xiaobo ^{[8
]}

Hu, Shulei ^{[1
]}

Yang, Xiuna ^{[3
,4
]}

Wang, Jiang ^{[1
,6
]}

Liu, Xiang ^{[9
]}

Xiao, Gengfu ^{[5
]}

Jiang, Hualiang ^{[1
,3
,4
,6
]}

Rao, Zihe ^{[3
,4
]}

Zhang, Lei-Ke ^{[5
]}

Xu, Yechun ^{[1
,6
]}

Yang, Haitao ^{[3
,4
]}

Liu, Hong ^{[1
,2
,6
,7
]}

机构：

[1] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, State Key Lab Drug Res, Shanghai 201203, Peoples R China

[2] China Pharmaceut Univ, Sch Pharm, Nanjing 210009, Jiangsu, Peoples R China

[3] ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Shanghai 201210, Peoples R China

[4] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China

[5] Chinese Acad Sci, Ctr Biosafety Mega Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China

[6] Univ Chinese Acad Sci, Beijing 100049, Peoples R China

[7] Nanjing Univ Chinese Med, Coll Pharm, Nanjing 210023, Peoples R China

[8] Sichuan Univ, Westchina Hosp, Natl Chengdu Ctr Safety Evaluat Drugs, Chengdu 610041, Sichuan, Peoples R China

[9] Nankai Univ, State Key Lab Med Chem Biol, Frontiers Sci Ctr Cell Response, Coll Pharm,Coll Life Sci, Tianjin 300353, Peoples R China

来源：

SCIENCE | 2020年 / 368卷 / 6497期

基金：

中国国家自然科学基金;

关键词：

CORONAVIRUS; INHIBITORS; 3C;

D O I：

10.1126/science.abb4489

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is the etiological agent responsible for the global COVID-19 (coronavirus disease 2019) outbreak. The main protease of SARS-CoV-2, M-pro, is a key enzyme that plays a pivotal role in mediating viral replication and transcription. We designed and synthesized two lead compounds (11a and 11b) targeting M-pro. Both exhibited excellent inhibitory activity and potent anti-SARS-CoV-2 infection activity. The x-ray crystal structures of SARS-CoV-2 M-pro in complex with 11a or 11b, both determined at a resolution of 1.5 angstroms, showed that the aldehyde groups of 11a and 11b are covalently bound to cysteine 145 of M-pro. Both compounds showed good pharmacokinetic properties in vivo, and 11a also exhibited low toxicity, which suggests that these compounds are promising drug candidates.

引用

页码：1331 / +

页数：35

共 50 条

[21] Structure-based design of SARS-CoV-2 papain-like protease inhibitors
Jadhav, Prakash
Huang, Bo
Osipiuk, Jerzy
Zhang, Xiaoming
Tan, Haozhou
Tesar, Christine
Endres, Michael
Jedrzejczak, Robert
Tan, Bin
Deng, Xufang
Joachimiak, Andrzej
Cai, Jianfeng
Wang, Jun
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 264
[22] Structure-Based Drug Design of RdRp Inhibitors against SARS-CoV-2
Shehzadi, Kiran
Saba, Afsheen
Yu, Mingjia
Liang, Jianhua
TOPICS IN CURRENT CHEMISTRY, 2023, 381 (05)
[23] Structure-Based Drug Design of RdRp Inhibitors against SARS-CoV-2
Kiran Shehzadi
Afsheen Saba
Mingjia Yu
Jianhua Liang
Topics in Current Chemistry, 2023, 381
[24] Fragment Based Drug Discovery of SARS-CoV-2 Main Protease
Song, W.
Li, S.
Chan, A. W. E.
Coker, A.
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2021, 77 : C705 - C705
[25] Computer Aided Structure-Based Drug Design of Novel SARS-CoV-2 Main Protease Inhibitors: Molecular Docking and Molecular Dynamics Study
Kolybalov, Dmitry S.
Kadtsyn, Evgenii D.
Arkhipov, Sergey G.
COMPUTATION, 2024, 12 (01)
[26] In Silico Identification of Potential Inhibitors of the Main Protease of SARS-CoV-2 Using Combined Ligand-Based and Structure-Based Drug Design Approachc
Debnath, Bimal
Saha, Apu Kr
Bhaumik, Samhita
Debnath, Sudhan
EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY, 2020, 4 (04): : 336 - 348
[27] Structure-Based Design of Potent Peptidomimetic Inhibitors Covalently Targeting SARS-CoV-2 Papain-like Protease
Wang, Qian
Chen, Guofeng
He, Jian
Li, Jiameng
Xiong, Muya
Su, Haixia
Li, Minjun
Hu, Hangchen
Xu, Yechun
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (10)
[28] Structure-Based Design of Novel Peptidomimetics Targeting the SARS-CoV-2 Spike Protein
Manikandan Alagumuthu
Sajjan Rajpoot
Mirza S. Baig
Cellular and Molecular Bioengineering, 2021, 14 : 177 - 185
[29] Structure-Based Design of Novel Peptidomimetics Targeting the SARS-CoV-2 Spike Protein
Alagumuthu, Manikandan
Rajpoot, Sajjan
Baig, Mirza S.
CELLULAR AND MOLECULAR BIOENGINEERING, 2021, 14 (02) : 177 - 185
[30] In-silico drug repurposing for targeting SARS-CoV-2 main protease (Mpro)
Sharma, Shilpa
Deep, Shashank
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (07): : 3003 - 3010

← 1 2 3 4 5 →